News

WHO has compiled a list of the top 10 threats to global health in 2019 and 6 of them are infectious disease-related.

The FDA has approved the use of the 0.5 mL dose of Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months.

The sNDAs will seek approval for the use of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate in individuals with HIV-1 whose virus is suppressed and are switching from a stable antiretroviral regimen.

A study of the approach worked wonders in China, but it may not effectively shift the burden of costs associated with testing in the US.

As the government shutdown passes the 1-month mark, Contagion® investigates how it is affecting public health agencies.

Applying hospital-based outbreak tools helped researchers identify a community MRSA outbreak

Investigators wanted to know if using linezolid in place of ethambutol in the treatment of pulmonary TB might shorten treatment times. The results of a new study show the swap worked, but not as well as other therapies.

Authors of a new report in JAMA introduce the 4 moments of antibiotic decision making, an easy-to-remember method that can be incorporated in real-time clinical practice.

A new review shows transgender women face higher HIV rates than transgender men, but also finds a relative lack of data about transmen.

In a multi-institution collaboration assessing 22 influenza forecasting models, the majority of models consistently showed higher accuracy than historical baseline models.

An outbreak in California of wound botulism associated with black tar heroin emphasizes the need of raising awareness about the risk of infectious diseases related to the opioid epidemic.

An investigative maternal vaccine for respiratory syncytial virus (RSV) could soon alter the scope of care for the condition, which is the most common cause of bronchiolitis and pneumonia in children younger than 1 year in the US.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new portable metagenomic technology allowed investigators to perform real-time analysis of viral genomes during a 2018 Lassa fever outbreak in Nigeria.

A large percentage of individuals with a documented allergy to penicillin can actually be treated safely with this class of antibiotics. It just requires careful evaluation and management on the part of health care providers.

In a new study, Michigan State University investigators identified an immune receptor, SLAMF7, that had the ability to decrease immune response when activated on monocytes.

While young people with enteric infections have the lion’s share of symptoms, the elderly suffer higher rates of complications and hospitalizations from these illnesses. Arriving at a correct, timely diagnosis for this cohort of patients is key.

A new analysis reports that 1 in 4 infants with bronchiolitis was given an antibiotic despite the fact that 70% of patients did not meet prescribing recommendations set by the American Academy of Pediatrics.

A new test can detect Plasmodium falciparum gametocyte carriers in saliva samples, providing a point-of-need rapid diagnostic test for malaria.

CDC has released mid-season estimates indicating approximately 84,000 Americans have been hospitalized for the influenza so far this season.

FDA has granted Fast Track designation for ACX-362E, an investigational new treatment for C diff that is being developed by Acurx Pharmaceuticals, LLC.

Health care providers in the US should be aware of an outbreak of an antibiotic-resistant strain of Pseudomonas aeruginosa at a Mexico hospital where US residents frequently undergo invasive medical procedures.

Program supported by Atrium Health and Heineman Foundation looks to educate local physicians on proper prescribing, stewardship.

Better rates of overall survival were seen when patients received granulocyte transfusions within 7 days of neutropenic sepsis.

To explore the long-term outcomes of treatment for recurrent C diff, NIAID has launched a new trial that will follow patients for 4 years to assess the safety of fecal microbiota transplants.

Focus group-based study reveals challenges in travel medicine among US-based visitors to the region.

New evidence suggests that use of certain opioids may increase the risk of developing pneumonia, particularly in patients with HIV.